Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-Current Deferred Tax Liability (2016 - 2023)

Historic Non-Current Deferred Tax Liability for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Q3 2023 value amounting to $201000.0.

  • Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability fell 1694.21% to $201000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $201000.0, marking a year-over-year decrease of 1694.21%. This contributed to the annual value of $144000.0 for FY2022, which is 7303.37% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Non-Current Deferred Tax Liability stood at $201000.0 for Q3 2023, which was down 1694.21% from $201000.0 recorded in Q2 2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability ranged from a high of $2.9 million in Q3 2021 and a low of $144000.0 during Q4 2022
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $755000.0 (2021), whereas its average is $726105.3.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability skyrocketed by 25249.09% in 2021, and later crashed by 9165.8% in 2022.
  • Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability (Quarter) stood at $867000.0 in 2019, then decreased by 14.53% to $741000.0 in 2020, then decreased by 27.94% to $534000.0 in 2021, then tumbled by 73.03% to $144000.0 in 2022, then skyrocketed by 39.58% to $201000.0 in 2023.
  • Its Non-Current Deferred Tax Liability stands at $201000.0 for Q3 2023, versus $201000.0 for Q2 2023 and $178000.0 for Q1 2023.